WHAT'S THIS?

Home About us Email sign up Basics Commentary - General - Best practice - Clinical trial registries - Selective publication - Industry payments Viewpoints Press releases Resources Directory

This is a freely accessible online resource for everyone involved in publication planning. Help us build the site into a valuable resource for, amongst others, medical writers and communications professionals, pharmaceutical industry managers, medical journal editors and publishers. Please send your ideas, contributions and comments about the articles to the Editor of The Publication Plan, Mary Greenacre. If you have any other comments about the service, the web site, or questions about advertising and sponsorship, please contact the Publisher, Peter Llewellyn.

Related Sites

COMMENTARY << Industry payments

Industry funding Published 10 December 2008 More from JAMA on the investigations of US senators into industry funding and conflict of interest. [Link to original source material]

US psychiatrist is fired from radio programme for not disclosing drug company ties Published 9 December 2008 The BMJ reports further fall-out from the ongoing investigations of US senators into industry funding and conflicts of interest. [Link to original source material]

Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont Published 5 November 2008 More from JAMA on pharma company payments. [Link to original source material]

GlaxoSmithKline to limit payments it makes to US doctors to $150,000 a year Published 30 October 2008 More from the BMJ on industry payments to doctors. [Link to original source material]

US university sets up conflict of interest office after investigation into drug company payments Published 21 October 2008 More from the BMJ on fall-out from the US Senate Finance Committee investigations into pharma company payments. [Link to original source material]

Drug funding questioned Published 8 October 2008 This article in JAMA provides an update on the investigation by the US Senate Finance Committee into pharma company funding of the American Psychiatric Association [Link to original source material]

Industry payments: Truly independent research is impossible Published 2 October 2008 Letter in response to a previous BMJ article questioning the independence of CROs from pharma companies sponsoring research. [Link to original source material]

Industry support of medical education Published 3 September 2008 (JAMA, Relman) End of the free lunch? Published 26 August 2008 (BMJ, Gould) Continuing medical education in the 21st century Published 22 August 2008 (BMJ, Woollard) A historical perspective of pharmaceutical promotion and physician education Published 20 August 2008 (JAMA, Podolsky) Rethinking continuing medical education Published 14 August 2008 (BMJ, Pisacane) Is the relationship between pharma and medical education on the rocks? Published 14 August 2008 (BMJ, Moynihan) Pharma and CME: view from the US Published 14 August 2008 (BMJ, Fletcher) Read five articles from the BMJ and two from JAMA on pharma sponsorship of CME - the hot topic for summer 2008. One of the articles (Gould, BMJ) presents an industry point of view from the medical director of the ABPI and an independent industry consultant. [Link to original source material] (JAMA, Relman) [Link to original source material] (BMJ, Gould) [Link to original source material] (Woollard, BMJ) [Link to original source material] (JAMA, Podolsky) [Link to original source material] (BMJ, Pisacane) [Link to original source material] (BMJ, Moynihan) [Link to original source material] (BMJ, Fletcher)

New developments in managing physician/industry relationships Published 3 September 2008 A commentary in JAMA on developments in the US on managing industry payments to doctors. [Link to original source material]

Any affiliation can lead to bias Published 11 August 2008 This article responds to a previous BMJ article that describes a list of medical experts without industry associations. It points out that any affiliation, not just those to commercial companies, can lead to bias, and that much high quality, honest work is done outside of academic institutions. [Link to original source material]

Disclosure of industry payments to physicians Published 7 August 2008 This NEJM article discusses the US Physician Payments Sunshine Act, whereby pharma and medical device and supplies companies who provide products to Medicare, Medicaid or the State Children's Health Insurance Program may have to declare all payments and gifts made to US physicians. [Link to original source material]

Naming names: is there an (unbiased) doctor in the house? Published 23 July 2008 This BMJ article describes a list that aims to provide a source for medical journalists of independent medical experts without industry associations. [Link to original source material]

Key opinion leaders: independent experts or drug representatives in disguise? Published 21 June 2008 This article by Ray Moynihan in the BMJ criticises the use of key opinion leaders by the pharma industry to communicate information on their products. The article is accompanied by an editorial by the BMJ Editor, Fiona Godlee, and a Head to Head debate on the issue with Charlie Buckwell (Complete Medical Group) and Giovanni Fava (University of Bologna). [Link to original source material]

Researchers fail to reveal full drug pay Published 8 June 2008 Here, the New York Times reports details of doctors from Harvard Medical School who failed to report considerable payments from the pharma industry. [Link to original source material]

WHAT ELSE?

This web site and associated activities are being managed by NetworkPharma Ltd, 89 Oxford Road, Oxford, OX2 9PD, UK
Telephone +44 (0) 1865 865943 Email: support@networkpharma.com

Other services managed by NetworkPharma
[www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsNetworking.co.uk] [www.ThePharmYard.com]